Effect of a SGLT2 inhibitor on the systemic and intrarenal renin–angiotensin system in subtotally nephrectomized rats-Reference-Cited by-同舟云学术

Effect of a SGLT2 inhibitor on the systemic and intrarenal renin–angiotensin system in subtotally nephrectomized rats

Published:2018-06 Issue:2 Volume:137 Page:220-223
ISSN:1347-8613
Container-title:Journal of Pharmacological Sciences
language:en
Short-container-title:Journal of Pharmacological Sciences

Author:

Li Lei,Konishi Yoshio,Morikawa Takashi,Zhang Yifan,Kitabayashi Chizuko,Kobara Hideki,Masaki Tsutomu,Nakano Daisuke,Hitomi Hirofumi,Kobori Hiroyuki,Nishiyama Akira

Funder

Mitsubishi Tanabe Pharma Corporation

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine

Reference15 articles.

1. SGLT2 mediates glucose reabsorption in the early proximal tubule;Vallon;J Am Soc Nephrol,2011

2. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N Engl J Med,2015

3. Empagliflozin and progression of kidney disease in type 2 diabetes;Wanner;N Engl J Med,2016

4. Influence of renal function on the 52-week efficacy and safety of the sodium glucose cotransporter 2 inhibitor luseogliflozin in Japanese patients with type 2 diabetes mellitus;Haneda;Clin Ther,2016

5. Effects of diuretics on sodium-dependent glucose cotransporter 2 inhibitor-induced changes in blood pressure in obese rats suffering from the metabolic syndrome;Rahman;J Hypertens,2016

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium-glucose cotransporter 2 inhibitors and renin-angiotensin-aldosterone system, possible cellular interactions and benefits;Cellular Signalling;2024-10

2. N–Si Heterolysis by Chiral (BOX)Cu(OTf)₂ Catalysts for the Synthesis of Indole and Carbazole Glycosides;Organic Letters;2024-06-03

3. Sodium Glucose Cotransporter-2 Inhibitors in Non-Diabetic Kidney Disease: Evidence in Experimental Models;Pharmaceuticals;2024-03-11

4. Potential use of sodium glucose co-transporter 2 inhibitors during acute illness: a systematic review based on COVID-19;Endocrine;2024-03-06

5. Obesity-related glomerulopathy: recent advances in inflammatory mechanisms and related treatments;Journal of Leukocyte Biology;2024-03-01